GlassScriptPhysician profile
Tracy D Davis
NPI 1578647277
$2,286.88
in general payments reported to CMS, 2019-2025
12 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.33 · 2023: $456 · 2024: $157 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,284 · Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,284.12 |
| Food and Beverage | $966.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,515.46 | 2025 | Evarrest |
| Baxter Healthcare | $317.66 | 2023-2024 | Floseal, Coseal, Preveleak |
| Abiomed | $229.71 | 2023-2025 | Impella |
| Cvrx, INC. | $54.31 | 2023-2024 | Barostim Neo System |
| La Jolla Pharmaceutical Company | $26.03 | 2024 | Giapreza |
| Ethicon US, LLC | $25.48 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal |
| Octapharma USA, INC. | $24.89 | 2025 | Fibryga |
| Alnylam Pharmaceuticals INC. | $23.51 | 2023 | Amvuttra |
| Atricure, INC. | $19.85 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.91 | 2023 | Xarelto |
| Kls-Martin L.P. | $16.59 | 2025 | |
| Silk Road Medical, INC. | $16.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.